MedTrace Logo

Quality of Tuberculosis Care in Urban Patna, India

NCT02874716 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 321

Last updated 2017-03-22

No results posted yet for this study

Summary

The purpose of this study is to evaluate the impact of the Private Provider Interface Agency (PPIA) program on quality of health care. The PPIA is a tuberculosis pilot program implemented in the private health sector of urban Patna in the state of Bihar, India.

Conditions

Interventions

OTHER

Tuberculosis Program (PPIA)

The intervention includes a variety of (1) non-financial incentives that are intended to reduce clinical and financial costs for presumptive TB patients and TB cases for diagnostic testing and treatment (free sputum microscopy, free digital chest X-ray, free or subsidized drug-susceptibility testing (DST), free first line anti-TB treatment), (2) training or certified medical education sessions for the providers from the PPIA, and (3) financial incentives to engaged providers for patient registration, diagnostic testing, treatment initiation, and treatment adherence. Meanwhile, health camps, advertising, and other advocacy efforts are aimed to raise awareness in the communities.

Sponsors & Collaborators

  • World Bank

    collaborator OTHER

  • Institute of Socio-Economic Research on Development and Democracy (ISERDD)

    collaborator UNKNOWN

  • ACCESS Health International

    collaborator OTHER

  • McGill University

    lead OTHER

Principal Investigators

  • Madhukar Pai, MD, PhD · McGill University

  • Jishnu Das, PhD · World Bank

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-07-31
Completion
2016-12-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02874716 on ClinicalTrials.gov